<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Zhou W</submitter><funding>National Institute of Allergy and Infectious Diseases</funding><funding>Thailand Science Research and Innovation</funding><funding>NIAID NIH HHS</funding><funding>National Natural Science Foundation of China</funding><funding>NIH HHS</funding><pagination>2411-2419</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8577183</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>84(9)</volume><pubmed_abstract>The soil bacterium &lt;i>Streptomyces pactum&lt;/i> ATCC 27456 produces a number of polyketide natural products. Among them is NFAT-133, an inhibitor of the nuclear factor of activated T cells (NFAT) that suppresses interleukin-2 (IL-2) expression and T cell proliferation. Biosynthetic gene inactivation in the ATCC 27456 strain revealed the ability of this strain to produce other polyketide compounds including analogues of NFAT-133. Consequently, seven new derivatives of NFAT-133, TM-129-TM-135, together with a known compound, panowamycin A, were isolated from the culture broth of &lt;i>S. pactum&lt;/i> ATCC 27456 Δ&lt;i>ptmTDQ&lt;/i>. Their chemical structures were elucidated on the basis of their HRESIMS, 1D and 2D NMR spectroscopy, and ECD calculation and spectral data. NFAT-133, TM-132, TM-135, and panowamycin A showed no antibacterial activity or cytotoxicity, but weakly reduced the production of LPS-induced nitric oxide in RAW264.7 cells in a dose-dependent manner. A revised chemical structure of panowamycin A and proposed modes of formation of the new NFAT-133 analogues are also presented.</pubmed_abstract><journal>Journal of natural products</journal><pubmed_title>Identification and Biological Activity of NFAT-133 Congeners from &lt;i>Streptomyces pactum&lt;/i>.</pubmed_title><pmcid>PMC8577183</pmcid><funding_grant_id>S10 OD018518</funding_grant_id><funding_grant_id>AI129957</funding_grant_id><funding_grant_id>81872795</funding_grant_id><funding_grant_id>R01 AI129957</funding_grant_id><funding_grant_id>PHD/0007/2558</funding_grant_id><pubmed_authors>Lan WJ</pubmed_authors><pubmed_authors>Ju Z</pubmed_authors><pubmed_authors>Liu XJ</pubmed_authors><pubmed_authors>Mahmud T</pubmed_authors><pubmed_authors>Zhou W</pubmed_authors><pubmed_authors>Posri P</pubmed_authors></additional><is_claimable>false</is_claimable><name>Identification and Biological Activity of NFAT-133 Congeners from &lt;i>Streptomyces pactum&lt;/i>.</name><description>The soil bacterium &lt;i>Streptomyces pactum&lt;/i> ATCC 27456 produces a number of polyketide natural products. Among them is NFAT-133, an inhibitor of the nuclear factor of activated T cells (NFAT) that suppresses interleukin-2 (IL-2) expression and T cell proliferation. Biosynthetic gene inactivation in the ATCC 27456 strain revealed the ability of this strain to produce other polyketide compounds including analogues of NFAT-133. Consequently, seven new derivatives of NFAT-133, TM-129-TM-135, together with a known compound, panowamycin A, were isolated from the culture broth of &lt;i>S. pactum&lt;/i> ATCC 27456 Δ&lt;i>ptmTDQ&lt;/i>. Their chemical structures were elucidated on the basis of their HRESIMS, 1D and 2D NMR spectroscopy, and ECD calculation and spectral data. NFAT-133, TM-132, TM-135, and panowamycin A showed no antibacterial activity or cytotoxicity, but weakly reduced the production of LPS-induced nitric oxide in RAW264.7 cells in a dose-dependent manner. A revised chemical structure of panowamycin A and proposed modes of formation of the new NFAT-133 analogues are also presented.</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Sep</publication><modification>2025-04-04T13:57:39.762Z</modification><creation>2025-04-04T13:57:39.762Z</creation></dates><accession>S-EPMC8577183</accession><cross_references><pubmed>34519213</pubmed><doi>10.1021/acs.jnatprod.1c00152</doi></cross_references></HashMap>